Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 7Uterine Cervical Neoplasms 4Vaginal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Pancreatic Neoplasms 2Neuroendocrine Tumors 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Thrombocythemia, Essential 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Adenocarcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1

Interventions

Radiotherapy 3entinostat 2Trastuzumab 2Nivolumab 2Ipilimumab 2CTLA-4 Antigen 2tipifarnib 1oncogene protein E7, Human papillomavirus type 16 1fludarabine phosphate 1fludarabine 1bintrafusp alfa protein, human 1aldesleukin 1Watchful Waiting 1Therapeutics 1Specimen Handling 1Ritonavir 1Respiratory Function Tests 1Radiation 1Psychiatric Rehabilitation 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1Observation 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Vulvar Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00335998 2013-01-11

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡